Posted on 4/24/19
Boston Scientific's Use Of Adjusted Earnings Distorts Valuations
SummaryThe Company's regular use one-time charges due to acquisitions and litigation gives it a high price-to-earnings multiple based on unadjusted earnings.In April, the FDA ordered the . . .
Posted on 4/24/19
Lawrence General Hospital RNs Reach Tentative Agreement
After 13 hours of negotiations that ended after 1 a.m. on Friday morning the nurses of Lawrence General Hospital reached a tentative agreement with management for . . .
Posted on 4/24/19
Verastem Oncology Announces Amendment to Refinance Hercules Loan Facility
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq: VSTM) operating as Verastem Oncology, focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer . . .
Posted on 4/23/19
Mispro Launches Insourcing Services for Vivarium Research Facilities
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mispro Biotech Services today announced expansion of its services into the Massachusetts biotechnology supercluster with its on-site vivarium services solution, Mispro Insource. Mispro Insource is . . .
Posted on 4/23/19
Sherlock Biosciences Closes $31M Series A
Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster, and more affordable
Posted on 4/23/19
Stewart’s Ambulance Service/Transformative Healthcare Expands into 4 Maine and N.H. Seacoast Communities
MEREDITH, N.H.--(BUSINESS WIRE)--Stewart’s Ambulance Service is expanding into four Maine and New Hampshire Seacoast communities through new contracts to provide municipal 911 Emergency Medical Services (EMS) . . .
Posted on 4/23/19
IPO Update: Trevi Therapeutics Proposes IPO Terms
SummaryTrevi Therapeutics has filed proposed terms for a $70 million IPO of its common stock.The firm is advancing programs led by its primary compound, nalbuphine ER.IPO . . .
Posted on 4/23/19
Better Buy: Biogen vs. AbbVie
Healthcare stocks have been hammered recently after the market seemed to suddenly wake up to the possibility that politicians may make some policy changes that cut . . .
Posted on 4/22/19
TransMedics Group On Deck For IPO
TransMedics Group (TMDX) has filed a preliminary prospectus for an $86M IPO.The Andover, MA-based medical technology firm has developed a product that it believes is a . . .
Posted on 4/22/19
Better Buy: Walgreens Boots Alliance vs. CVS Health
Walgreens Boots Alliance (NASDAQ:WBA) and CVS Health (NYSE:CVS) are being left behind as the S&P 500 index chalks up nice gains in 2019. Shares of both . . .
Posted on 4/19/19
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity . . .
Posted on 4/18/19
Indalo Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead Antifibrotic Drug Candidate IDL-2965
Indalo Therapeutics, a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis . . .
Posted on 4/18/19
Arrakis Therapeutics Raises $75M Series B Financing
Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small-molecule medicines that directly target RNA, has completed a $75 million Series B
Posted on 4/18/19
Talaris Therapeutics Raises $100M Series A Financing
Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to eliminate the burden of chronic immunosuppression
Posted on 4/18/19
Here's Why Shares of bluebird bio Slumped Today
What happenedShares of bluebird bio (NASDAQ:BLUE) closed with a 9.5% drop on Wednesday, having been down as much as 10.3%, on no apparent news.So whatThe biotech . . .
Posted on 4/17/19
Owl Labs Raises $15M in Series B Funding
Owl Labs, the video conferencing company and creator of the smart 360° conferencing camera Meeting Owl, has raised $15 million in a Series B investment
Posted on 4/17/19
PureTech Health Announces Collaboration with Boehringer Ingelheim
BOSTON--(BUSINESS WIRE)--PureTech Health plc (LSE: PRTC), an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis, today announced that it has entered . . .
Posted on 4/17/19
2019’s Best & Worst States for Children’s Health Care – WalletHub Study
Raising a child in America is extremely expensive, costing the average parent over $230k, and health care accounts for a big chunk of the bill. And . . .
Posted on 4/17/19
Why Celgene Shareholders Should Hold On to Their Bristol-Myers Squibb Stock Once the Acquisition Closes
Sure, there was some drama along the way with Bristol-Myers Squibb's (NYSE:BMY)proposed acquisition of Celgene (NASDAQ:CELG). But it never made sense to bet against the deal. . . .
Posted on 4/16/19
Myomo Announces New Sales and Service Agreement for Chile
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, . . .
Posted on 4/15/19
Twist Bioscience and iGEM Partner
SAN FRANCISCO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon . . .
Posted on 4/15/19
EI Pharma Closes $11.2 Million Financing Round
EIP Pharma, a CNS-focused therapeutics company, announced today the successful completion of $11.2 million in new private funding to explore
Posted on 4/15/19
Better Buy: Gilead Sciences vs. Biogen
If you're looking for hot biotech stocks, neither Gilead Sciences (NASDAQ:GILD) nor Biogen(NASDAQ:BIIB) is likely to appeal to you right now. Gilead is up by a . . .
Posted on 4/15/19
Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
Two of the hottest biotech stocks on the market right now are GW Pharmaceuticals(NASDAQ:GWPH) and Cara Therapeutics (NASDAQ:CARA). Shares of GW have soared more than 70% . . .
Posted on 4/15/19
Bristol-Myers Squibb Shareholders Approve Celgene Acquisition
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that its shareholders voted to approve the issuance of shares of Bristol-Myers Squibb common stock in connection . . .

